China Universal Asset Management »

Sana Biotechnology shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Sana Biotechnology (SANA) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Sana Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Sana Biotechnology held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sana Biotechnology by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $424k 42k 10.00
2023-12-31 $93k 23k 4.08
2023-09-30 $20k 5.0k 3.96
2023-06-30 $15k 2.5k 5.98
2023-03-31 $8.0k 2.6k 3.10
2022-12-31 $8.0k 1.9k 4.13
2022-09-30 $11k 1.8k 6.18

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Sana Biotechnology

Flagship Ventures Management
Baillie Gifford & Co
Vanguard Group
T. Rowe Price Associates
Crestline Management
Alphabet
Millennium Management
Baker Bros. Advisors
Partner Fund Management
Jpmorgan Chase & Co
Massachusetts Financial Services
Omega Fund Management
Goldman Sachs Group
Charles Schwab Investment Management
Arrowpoint Asset Management

View all funds holding Sana Biotechnology